Preferred test for detecting herpes simplex virus (HSV) infection in CSF, neonates, or when rapid diagnostic test for suspected HSV infection is necessary.
Qualitative Polymerase Chain Reaction
New York DOH Approval Status
Lavender (EDTA), pink (K2EDTA), or serum separator tube. OR Amniotic fluid, bronchoalveolar lavage (BAL), CSF, ocular fluid, tissue, vesicle fluid. OR Endocervical specimen in ThinPrep® Pap Test media.
Separate plasma or serum from cells. Transfer 1 mL serum, plasma, amniotic fluid, BAL, CSF, ocular fluid, or ThinPrep specimen to a sterile container. (Min: 0.5 mL)
Tissue: Transfer to a sterile container and freeze immediately.
Vesicle Fluid: Transfer to viral transport media (ARUP supply #12884). Available online through eSupply using ARUP Connect™ or contact ARUP Client Services at (800) 522-2787.
Heparinized specimens, tissues in optimal cutting temperature compound.
Specimen source required.
Tissue: Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 3 months
All Others: Ambient: 8 hours; Refrigerated: 72 hours; Frozen: 3 months
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
|Component Test Code*||Component Chart Name||LOINC|
|0050102||Herpes Simplex Virus Source||31208-2|
|0060041||Herpes Simplex Virus by PCR||5014-6|
- Herpes Simplex Virus, Type 1/2 DNA, Real-Time PCR,
- HSV Types 1 and 2